Akouda Patassi

Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors

Risk Factors and Mortality Associated With Resistance to First-Line Antiretroviral Therapy

<p>Antimicrobial Resistance: Implications and Costs</p>

Catechins containing a galloyl moiety as potential anti-HIV-1 compounds

High prevalence of HIV‐1 drug resistance among patients on first‐line antiretroviral treatment in Lomé, Togo